Invention Grant
- Patent Title: Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
-
Application No.: US15771809Application Date: 2016-10-27
-
Publication No.: US10912794B2Publication Date: 2021-02-09
- Inventor: Geoffrey Paul Horst , Robert Bernard Levine
- Applicant: ALGAL SCIENTIFIC CORPORATION
- Applicant Address: US MI Plymouth
- Assignee: ALGAL SCIENTIFIC CORPORATION
- Current Assignee: ALGAL SCIENTIFIC CORPORATION
- Current Assignee Address: US MI Plymouth
- Agency: Nyemaster Goode P.C.
- International Application: PCT/US2016/059192 WO 20161027
- International Announcement: WO2017/075262 WO 20170504
- Main IPC: A61K31/716
- IPC: A61K31/716 ; A61K35/68 ; A61K45/06 ; A61P39/00 ; A61P1/00 ; A61P3/00 ; A61P3/06 ; A61P31/04 ; A61P37/04 ; A23L33/125 ; A61K9/14 ; A61K33/30 ; A61K39/39 ; A61K39/00
Abstract:
The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
Public/Granted literature
- US20180311271A1 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION Public/Granted day:2018-11-01
Information query
